Cefdinir Capsule
Product Images NDC 72789-054

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 72789-054). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789054 Label (72789054)

72789054 Label (72789054)
This is a medication warning label for Cefdinir USP, 300 mg capsules, which comes in a bottle of 20 capsules. The LOT number is BzoDS7 and the expiration date is 10/2021. Patients are advised to finish the medication unless otherwise advised by their doctor and to call their doctor for medical advice regarding any side effects. Each capsule contains 300 mg of Cefdinir USP. There are some illegible text and misplaced characters throughout the label.*
FDA Label Image

Chemical Structure (Cefdinir Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.